Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Michael G. Shlipak(San Francisco VA Health Care System), Catherine Stehman‐Breen(Amgen (United States))
Cited by 1,248
Related Papers
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
|New England Journal of Medicine|2013|968
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
|The Lancet Diabetes & Endocrinology|2015|897
Multiple loci associated with indices of renal function and chronic kidney disease
|Nature Genetics|2009|658
Inflammation and Progression of CKD: The CRIC Study
|Clinical Journal of the American Society of Nephrology|2016|441